Experience superior respiratory management with Fluticasone Furoate and Vilanterol ELLIPTA Inhalation Powder by Prasco Labs. Specifically designed to address the needs of individuals suffering from asthma and chronic obstructive pulmonary disease (COPD), this product offers a convenient and effective solution to managing chronic respiratory conditions. With its innovative delivery system and dual-active formulation, it optimizes lung function and enhances breathing ease, empowering you to live an active and healthier life.
Product Details and Features:
Advanced Combination Therapy: Combines Fluticasone Furoate, a potent corticosteroid, with Vilanterol, a long-acting beta agonist (LABA), to provide long-term relief and prevent flare-ups.
Innovative ELLIPTA Device: Features a user-friendly inhaler design with a pre-set dose and integrated dose counter to enhance adherence and medication tracking.
Smooth Operation: The ELLIPTA inhaler requires minimal steps and allows single daily dosing, improving ease of use and reducing treatment burden.
Once-Daily Convenience: Provides 24-hour pulmonary support with just one inhalation per day, making it a time-efficient option for patients.
Mechanism of Action:
Fluticasone Furoate: Acts as an anti-inflammatory agent that reduces lung inflammation and irritation, decreasing the frequency and severity of asthma attacks.
Vilanterol: Functions as a bronchodilator, relaxing the smooth muscle in the airways to improve airflow, reduce bronchospasm, and ease breathing over an extended period.
Directions for Use:
1. Daily Inhalation: Administer one inhalation once a day, at the same time each day for optimal results.
2. Activation and Usage: Slide the cover down until you hear a click, which prepares the dose. Exhale fully, then place the mouthpiece between your lips and take a steady, deep breath. Hold your breath for about 3-4 seconds to allow the medication to reach deep into the lungs.
3. Cleaning: Maintain the hygiene of the mouthpiece by wiping it with a dry tissue regularly. Do not wash in water.
4. Storage: Store in a cool, dry place, ensuring the device is closed when not in use. Protect from moisture and heat.
Warnings:
-
Not for Acute Treatment: This inhaler does not serve as a rescue inhaler for asthma attacks or acute symptoms. Always have a fast-acting inhaler available for sudden breathing problems.
-
Asthma-Related Death Risk: Using LABA alone can increase the risk of worsening asthma symptoms or asthma-related death. This risk is mitigated when used as a prescribed combination therapy.
-
Monitor Bone Density: Long-term use of corticosteroids may impact bone mineral density. Monitor calcium and vitamin D intake and discuss any concerns with your healthcare provider.
-
Allergic Reactions: Discontinue use immediately if you experience signs of an allergic reaction, including rash, itching, swelling, severe dizziness, or difficulty breathing.
Side Effects:
-
Common Side Effects: May include throat irritation, hoarseness, headache, gastrointestinal discomfort, and nasal congestion.
-
Serious Side Effects: These can include symptoms of infection such as fever, persistent sore throat, mental/mood changes, severe muscle weakness, vision problems, and possible cardiovascular effects, such as palpitations or increased heart rate. Seek medical attention if any severe side effects occur.
-
Risk of Thrush: Oral thrush may occur; it's recommended to rinse your mouth with water without swallowing after each inhalation to prevent this.
By choosing Fluticasone Furoate and Vilanterol ELLIPTA Inhalation Powder from Prasco Labs, you are selecting a high-caliber solution specifically engineered for dual coverage of your respiratory health needs. Enhance your quality of life with this all-encompassing and innovative approach to asthma and COPD management.
Skip to content
